Clinical Trials Browser

Phase 2/3 × Pancreatic Ductal Adenocarcinoma × Clear all

NCT06079346 2024-08-13

STOP-PC

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05955157 2024-01-10

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Phase 2/3 Unknown

GastrointestinalOther solid neoplasm

Pancreatic Ductal Adenocarcinoma